Posts

Psomagen, Inc. Partners with Swift Biosciences to Fill the Increasing Need for Genomic Surveillance of SARS-CoV-2 Variants

ROCKVILLE, MD — April 13 2021 — Psomagen, Inc., a US-based genetic sequencing and data analysis service provider, is collaborating with Swift Biosciences (now part of Integrated DNA Technologies), a pioneer in the development of research-use-only library preparation kits, to offer comprehensive SARS-CoV-2 variant determination using next-generation sequencing (NGS). Early in the pandemic, public health […]

COVID-19 Testing Industry Consortium Survey Helps Us Understand Pandemic’s Challenges

As one of the newest members of the COVID-19 Testing Industry Consortium, we wanted to share with you the results of our Back-to-Work survey. The survey, conducted last fall,  represents the experiences of 77 organizations across the United States. We hope the information inside will help us understand the intricacies of the ongoing pandemic challenges […]

The Role of Genes in the Severity of COVID-19 Symptoms

The new strain of coronavirus known as SARS-CoV-2 or COVID-19 is a highly contagious yet highly selective respiratory virus that continues to puzzle researchers and medical professionals. At first, it seemed as though only the elderly and those with underlying health conditions were at risk of developing severe symptoms and dying from the virus — […]

The Viral Evolution of COVID-19

To the knowledge of scientists and the CDC, the family of coronaviruses has been around since the mid-1960s. One of the most deadly of these viruses came about in the early 2000s when Severe Acute Respiratory Syndrome, otherwise known as SARS, emerged in China. A decade later, the Middle East Respiratory Syndrome (MERS) developed in […]